DCGO vs. LFMD, PSNL, CSTL, FTRE, EHAB, INNV, CELC, AUNA, TALK, and SBC
Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include LifeMD (LFMD), Personalis (PSNL), Castle Biosciences (CSTL), Fortrea (FTRE), Enhabit (EHAB), InnovAge (INNV), Celcuity (CELC), Auna (AUNA), Talkspace (TALK), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry.
DocGo vs. Its Competitors
LifeMD (NASDAQ:LFMD) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.
DocGo has a net margin of -0.12% compared to LifeMD's net margin of -4.58%. DocGo's return on equity of 2.52% beat LifeMD's return on equity.
LifeMD has a beta of 2.42, suggesting that its share price is 142% more volatile than the S&P 500. Comparatively, DocGo has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.
DocGo has higher revenue and earnings than LifeMD. DocGo is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.
DocGo received 8 more outperform votes than LifeMD when rated by MarketBeat users. However, 77.36% of users gave LifeMD an outperform vote while only 72.06% of users gave DocGo an outperform vote.
LifeMD presently has a consensus price target of $12.00, suggesting a potential downside of 14.59%. DocGo has a consensus price target of $3.56, suggesting a potential upside of 105.78%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than LifeMD.
In the previous week, LifeMD had 15 more articles in the media than DocGo. MarketBeat recorded 17 mentions for LifeMD and 2 mentions for DocGo. DocGo's average media sentiment score of 0.42 beat LifeMD's score of 0.25 indicating that DocGo is being referred to more favorably in the news media.
35.5% of LifeMD shares are held by institutional investors. Comparatively, 56.4% of DocGo shares are held by institutional investors. 18.4% of LifeMD shares are held by insiders. Comparatively, 2.7% of DocGo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
DocGo beats LifeMD on 10 of the 19 factors compared between the two stocks.
Get DocGo News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:DCGO) was last updated on 6/24/2025 by MarketBeat.com Staff
Buy DCGO Stock Free DCGO Stock Alerts